 Drug-Related Side Effects and Adverse Reactions
"Drug-Related Side Effects and Adverse Reactions" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Disorders that result from the intended use of PHARMACEUTICAL PREPARATIONS. Included in this heading are a broad variety of chemically-induced adverse conditions due to toxicity, DRUG INTERACTIONS, and metabolic effects of pharmaceuticals.
| Descriptor ID |
D064420
|
| MeSH Number(s) |
C25.100
|
| Concept/Terms |
Drug-Related Side Effects and Adverse Reactions- Drug-Related Side Effects and Adverse Reactions
- Drug Related Side Effects and Adverse Reactions
- Side Effects of Drugs
- Drug Side Effects
- Drug Side Effect
- Effects, Drug Side
- Side Effect, Drug
- Side Effects, Drug
- Adverse Drug Reaction
- Adverse Drug Reactions
- Drug Reaction, Adverse
- Drug Reactions, Adverse
- Reactions, Adverse Drug
- Adverse Drug Event
- Adverse Drug Events
- Drug Event, Adverse
- Drug Events, Adverse
Drug Toxicity- Drug Toxicity
- Toxicity, Drug
- Drug Toxicities
- Toxicities, Drug
|
Below are MeSH descriptors whose meaning is more general than "Drug-Related Side Effects and Adverse Reactions".
Below are MeSH descriptors whose meaning is more specific than "Drug-Related Side Effects and Adverse Reactions".
This graph shows the total number of publications written about "Drug-Related Side Effects and Adverse Reactions" by people in this website by year, and whether "Drug-Related Side Effects and Adverse Reactions" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1991 | 1 | 0 | 1 | | 1995 | 1 | 0 | 1 | | 1996 | 1 | 0 | 1 | | 1997 | 1 | 0 | 1 | | 1998 | 1 | 1 | 2 | | 1999 | 2 | 0 | 2 | | 2000 | 0 | 2 | 2 | | 2001 | 3 | 1 | 4 | | 2002 | 1 | 0 | 1 | | 2004 | 2 | 1 | 3 | | 2005 | 1 | 0 | 1 | | 2006 | 3 | 4 | 7 | | 2007 | 2 | 5 | 7 | | 2008 | 0 | 6 | 6 | | 2009 | 0 | 5 | 5 | | 2010 | 1 | 1 | 2 | | 2011 | 5 | 3 | 8 | | 2012 | 4 | 5 | 9 | | 2013 | 8 | 10 | 18 | | 2014 | 6 | 4 | 10 | | 2015 | 9 | 4 | 13 | | 2016 | 4 | 5 | 9 | | 2017 | 6 | 8 | 14 | | 2018 | 12 | 4 | 16 | | 2019 | 6 | 5 | 11 | | 2020 | 9 | 2 | 11 | | 2021 | 4 | 1 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Drug-Related Side Effects and Adverse Reactions" by people in Profiles.
-
Huynh L, Toyserkani GA, Morrato EH. Pragmatic applications of implementation science frameworks to regulatory science: an assessment of FDA Risk Evaluation and Mitigation Strategies (REMS) (2014-2018). BMC Health Serv Res. 2021 Aug 06; 21(1):779.
-
van Ingen J, Aliberti S, Andrejak C, Chalmers JD, Codecasa LR, Daley CL, Hasegawa N, Griffith DE, Hoefsloot W, Huitt G, Jarand J, Jhun BW, Loebinger MR, Marras TK, Morimoto K, Polverino E, Ringshausen FC, Santin M, Thomson R, Wagner D, Wallace RJ, Winthrop KL, Yim JJ. Management of Drug Toxicity in Mycobacterium avium Complex Pulmonary Disease: An Expert Panel Survey. Clin Infect Dis. 2021 07 01; 73(1):e256-e259.
-
Meissner K, Henthorn TK. How relevant is stereoselectivity to the side-effects of ketamine? Br J Anaesth. 2021 07; 127(1):1-2.
-
Huart C, Philpott CM, Altundag A, Fjaeldstad AW, Frasnelli J, Gane S, Hsieh JW, Holbrook EH, Konstantinidis I, Landis BN, Macchi A, Mueller CA, Negoias S, Pinto JM, Poletti SC, Ramakrishnan VR, Rombaux P, Vodicka J, Welge-Lüessen A, Whitcroft KL, Hummel T. Systemic corticosteroids in coronavirus disease 2019 (COVID-19)-related smell dysfunction: an international view. Int Forum Allergy Rhinol. 2021 07; 11(7):1041-1046.
-
Urman RD, Seger DL, Fiskio JM, Neville BA, Harry EM, Weiner SG, Lovelace B, Fain R, Cirillo J, Schnipper JL. The Burden of Opioid-Related Adverse Drug Events on Hospitalized Previously Opioid-Free Surgical Patients. J Patient Saf. 2021 03 01; 17(2):e76-e83.
-
Antoon JW, Hall M, Herndon A, Carroll A, Ngo ML, Freundlich KL, Stassun JC, Frost P, Johnson DP, Chokshi SB, Brown CM, Browning WL, Feinstein JA, Grijalva CG, Williams DJ. Prevalence of Clinically Significant Drug-Drug Interactions Across US Children's Hospitals. Pediatrics. 2020 11; 146(5).
-
Wang SV, Stefanini K, Lewis E, Newcomer SR, Fireman B, Daley MF, Glanz JM, Duffy J, Weintraub E, Kulldorff M. Determining Which of Several Simultaneously Administered Vaccines Increase Risk of an Adverse Event. Drug Saf. 2020 10; 43(10):1057-1065.
-
Villa Zapata L, Hansten PD, Horn JR, Boyce RD, Gephart S, Subbian V, Romero A, Malone DC. Evidence of Clinically Meaningful Drug-Drug Interaction With Concomitant Use of Colchicine and Clarithromycin. Drug Saf. 2020 07; 43(7):661-668.
-
Solms A, Willmann S, Reinecke I, Spiro TE, Peters G, Weitz JI, Mueck W, Garmann D, Schmidt S, Zhang L, Fox KAA, Berkowitz SD. Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in the treatment of venous thromboembolism. J Thromb Thrombolysis. 2020 Jul; 50(1):1-11.
-
Wang L, Blackley SV, Blumenthal KG, Yerneni S, Goss FR, Lo YC, Shah SN, Ortega CA, Korach ZT, Seger DL, Zhou L. A dynamic reaction picklist for improving allergy reaction documentation in the electronic health record. J Am Med Inform Assoc. 2020 06 01; 27(6):917-923.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|